Abstract
Venous thromboembolic events (VTE) are frequent during cancer and increase with age. Their preventions by anticoagulants in older patients with cancer has not been established and very few data exist in older frail subjects. The primary Objective: To compare the risk of VTE in older patients with cancer treated or not treated with preventive anticoagulant therapy. The secondary objectives are to assess the bleeding risk in both groups and to identify risk factors of VTE.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
